organic compounds
A correction has been published for this article. To view the correction, click here.
2-[4-(4,5-Dihydro-1H-pyrrol-2-yl)phenyl]-4,5-dihydro-1H-imidazole
aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, and bDepartment of Chemistry, School of Science, Payame Noor University (PNU), Ardakan, Yazd, Iran
*Correspondence e-mail: hkfun@usm.my
The molecule of the title compound, C12H14N4, lies about a crystallographic inversion centre. The five- and six-membered rings are twisted from each other, forming a dihedral angle of 18.06 (7)°. In the neighbouring molecules are linked by intermolecular N—H⋯N hydrogen bonds into one-dimensional infinite chains forming 18-membered rings with R22(18) motifs. The is further stabilized by weak intermolecular π–π stacking [centroid–centroid distance = 3.8254 (6) Å] and C—H⋯π interactions.
Related literature
For details of hydrogen-bond motifs, see: Bernstein et al. (1995). For a related structure and synthesis, see: Stibrany et al. (2004). For applications, see: Blancafort (1978); Chan (1993); Vizi (1986); Li et al. (1996); Ueno et al. (1995); Corey & Grogan (1999).
Experimental
Crystal data
|
Refinement
|
Data collection: APEX2 (Bruker, 2005); cell APEX2; data reduction: SAINT (Bruker, 2005); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2003).
Supporting information
10.1107/S160053680803818X/tk2331sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: 10.1107/S160053680803818X/tk2331Isup2.hkl
The synthetic method used for the preparation of (I) was based on previous work (Stibrany et al. 2004), except that 1,4-dicyanobenzene (10 mmol) and ethylenediamine (40 mmol) were used. Single crystals suitable for X-ray diffraction were obtained by evaporation of a methanol solution of (I) held at room temperature.
All hydrogen atoms were located from a difference Fourier map and refined freely: C—H ranged from 0.961 (16) to 1.015 (15) Å and N—H was 0.874 (18) Å.
Data collection: APEX2 (Bruker, 2005); cell
APEX2 (Bruker, 2005); data reduction: SAINT (Bruker, 2005); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2003).C12H14N4 | Z = 1 |
Mr = 214.27 | F(000) = 114 |
Triclinic, P1 | Dx = 1.437 Mg m−3 |
Hall symbol: -P 1 | Melting point: 312 K |
a = 4.8863 (2) Å | Mo Kα radiation, λ = 0.71073 Å |
b = 5.1472 (2) Å | Cell parameters from 3789 reflections |
c = 10.2295 (4) Å | θ = 2.5–30.3° |
α = 104.414 (2)° | µ = 0.09 mm−1 |
β = 93.885 (2)° | T = 100 K |
γ = 94.207 (2)° | Block, colourless |
V = 247.52 (2) Å3 | 0.56 × 0.17 × 0.15 mm |
Bruker SMART APEXII CCD area-detector diffractometer | 1296 independent reflections |
Radiation source: fine-focus sealed tube | 1208 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.026 |
ϕ and ω scans | θmax = 29.0°, θmin = 4.1° |
Absorption correction: multi-scan (SADABS; Bruker, 2005) | h = −6→6 |
Tmin = 0.950, Tmax = 0.986 | k = −6→6 |
4616 measured reflections | l = −13→13 |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.041 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.116 | All H-atom parameters refined |
S = 1.07 | w = 1/[σ2(Fo2) + (0.0717P)2 + 0.0714P] where P = (Fo2 + 2Fc2)/3 |
1296 reflections | (Δ/σ)max < 0.001 |
101 parameters | Δρmax = 0.42 e Å−3 |
0 restraints | Δρmin = −0.24 e Å−3 |
C12H14N4 | γ = 94.207 (2)° |
Mr = 214.27 | V = 247.52 (2) Å3 |
Triclinic, P1 | Z = 1 |
a = 4.8863 (2) Å | Mo Kα radiation |
b = 5.1472 (2) Å | µ = 0.09 mm−1 |
c = 10.2295 (4) Å | T = 100 K |
α = 104.414 (2)° | 0.56 × 0.17 × 0.15 mm |
β = 93.885 (2)° |
Bruker SMART APEXII CCD area-detector diffractometer | 1296 independent reflections |
Absorption correction: multi-scan (SADABS; Bruker, 2005) | 1208 reflections with I > 2σ(I) |
Tmin = 0.950, Tmax = 0.986 | Rint = 0.026 |
4616 measured reflections |
R[F2 > 2σ(F2)] = 0.041 | 0 restraints |
wR(F2) = 0.116 | All H-atom parameters refined |
S = 1.07 | Δρmax = 0.42 e Å−3 |
1296 reflections | Δρmin = −0.24 e Å−3 |
101 parameters |
Experimental. The low-temperature data was collected with the Oxford Cyrosystem Cobra low-temperature attachment. |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
N1 | 0.99649 (17) | 0.02202 (18) | 0.30177 (9) | 0.0140 (2) | |
N2 | 1.05027 (18) | 0.42785 (18) | 0.25064 (9) | 0.0161 (2) | |
C1 | 1.2376 (2) | 0.1595 (2) | 0.39310 (10) | 0.0148 (2) | |
C2 | 1.2547 (2) | 0.4433 (2) | 0.36664 (10) | 0.0158 (2) | |
C3 | 0.92585 (19) | 0.1869 (2) | 0.21989 (10) | 0.0124 (2) | |
C4 | 0.70754 (19) | 0.08912 (19) | 0.10716 (10) | 0.0124 (2) | |
C5 | 0.6787 (2) | 0.2263 (2) | 0.00581 (10) | 0.0138 (2) | |
C6 | 0.5270 (2) | −0.1391 (2) | 0.09997 (10) | 0.0135 (2) | |
H1A | 1.402 (3) | 0.062 (3) | 0.3667 (15) | 0.020 (3)* | |
H1B | 1.212 (3) | 0.169 (3) | 0.4906 (16) | 0.024 (4)* | |
H2A | 1.443 (3) | 0.498 (3) | 0.3429 (16) | 0.026 (4)* | |
H2B | 1.214 (3) | 0.587 (3) | 0.4488 (15) | 0.020 (3)* | |
H5 | 0.802 (3) | 0.383 (3) | 0.0096 (16) | 0.025 (4)* | |
H6 | 0.537 (3) | −0.239 (3) | 0.1687 (15) | 0.020 (3)* | |
H1N1 | 0.989 (3) | −0.151 (4) | 0.2656 (17) | 0.029 (4)* |
U11 | U22 | U33 | U12 | U13 | U23 | |
N1 | 0.0135 (4) | 0.0131 (4) | 0.0147 (4) | −0.0009 (3) | −0.0033 (3) | 0.0041 (3) |
N2 | 0.0147 (4) | 0.0150 (4) | 0.0177 (5) | −0.0009 (3) | −0.0044 (3) | 0.0047 (3) |
C1 | 0.0125 (4) | 0.0157 (5) | 0.0153 (5) | −0.0008 (3) | −0.0030 (3) | 0.0037 (4) |
C2 | 0.0144 (5) | 0.0153 (5) | 0.0167 (5) | −0.0011 (4) | −0.0038 (3) | 0.0041 (4) |
C3 | 0.0102 (4) | 0.0142 (5) | 0.0130 (4) | 0.0015 (3) | 0.0006 (3) | 0.0036 (3) |
C4 | 0.0098 (4) | 0.0134 (5) | 0.0133 (4) | 0.0009 (3) | 0.0000 (3) | 0.0025 (3) |
C5 | 0.0109 (4) | 0.0143 (5) | 0.0159 (5) | −0.0009 (3) | 0.0001 (3) | 0.0041 (3) |
C6 | 0.0128 (4) | 0.0140 (5) | 0.0142 (5) | 0.0002 (3) | 0.0003 (3) | 0.0049 (3) |
N1—C3 | 1.3780 (13) | C2—H2B | 1.015 (15) |
N1—C1 | 1.4700 (12) | C3—C4 | 1.4787 (13) |
N1—H1N1 | 0.874 (18) | C4—C5 | 1.3973 (14) |
N2—C3 | 1.2944 (13) | C4—C6 | 1.4000 (14) |
N2—C2 | 1.4808 (12) | C5—C6i | 1.3881 (13) |
C1—C2 | 1.5479 (14) | C5—H5 | 0.961 (16) |
C1—H1A | 0.997 (14) | C6—C5i | 1.3881 (13) |
C1—H1B | 1.004 (16) | C6—H6 | 0.970 (15) |
C2—H2A | 1.006 (16) | ||
C3—N1—C1 | 107.38 (8) | C1—C2—H2B | 112.1 (9) |
C3—N1—H1N1 | 118.4 (11) | H2A—C2—H2B | 106.8 (12) |
C1—N1—H1N1 | 119.9 (10) | N2—C3—N1 | 116.89 (9) |
C3—N2—C2 | 106.43 (8) | N2—C3—C4 | 123.28 (9) |
N1—C1—C2 | 102.00 (8) | N1—C3—C4 | 119.77 (9) |
N1—C1—H1A | 108.9 (8) | C5—C4—C6 | 118.99 (9) |
C2—C1—H1A | 112.8 (9) | C5—C4—C3 | 119.82 (9) |
N1—C1—H1B | 112.3 (9) | C6—C4—C3 | 121.19 (9) |
C2—C1—H1B | 111.4 (9) | C6i—C5—C4 | 120.61 (9) |
H1A—C1—H1B | 109.3 (12) | C6i—C5—H5 | 119.7 (9) |
N2—C2—C1 | 106.30 (8) | C4—C5—H5 | 119.6 (9) |
N2—C2—H2A | 109.2 (9) | C5i—C6—C4 | 120.40 (9) |
C1—C2—H2A | 111.9 (9) | C5i—C6—H6 | 117.6 (9) |
N2—C2—H2B | 110.6 (8) | C4—C6—H6 | 122.0 (9) |
C3—N1—C1—C2 | 9.79 (10) | N1—C3—C4—C5 | −165.14 (9) |
C3—N2—C2—C1 | 3.06 (11) | N2—C3—C4—C6 | −161.93 (10) |
N1—C1—C2—N2 | −7.84 (10) | N1—C3—C4—C6 | 15.11 (14) |
C2—N2—C3—N1 | 3.71 (12) | C6—C4—C5—C6i | 0.46 (16) |
C2—N2—C3—C4 | −179.17 (8) | C3—C4—C5—C6i | −179.29 (8) |
C1—N1—C3—N2 | −9.24 (12) | C5—C4—C6—C5i | −0.46 (16) |
C1—N1—C3—C4 | 173.53 (8) | C3—C4—C6—C5i | 179.29 (8) |
N2—C3—C4—C5 | 17.82 (14) |
Symmetry code: (i) −x+1, −y, −z. |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1N1···N2ii | 0.87 (2) | 2.18 (2) | 3.0060 (13) | 158.1 (15) |
C2—H2B···Cg1iii | 1.015 (15) | 2.980 (15) | 3.8882 (11) | 149.6 (11) |
Symmetry codes: (ii) x, y−1, z; (iii) −x, −y+1, −z+1. |
Experimental details
Crystal data | |
Chemical formula | C12H14N4 |
Mr | 214.27 |
Crystal system, space group | Triclinic, P1 |
Temperature (K) | 100 |
a, b, c (Å) | 4.8863 (2), 5.1472 (2), 10.2295 (4) |
α, β, γ (°) | 104.414 (2), 93.885 (2), 94.207 (2) |
V (Å3) | 247.52 (2) |
Z | 1 |
Radiation type | Mo Kα |
µ (mm−1) | 0.09 |
Crystal size (mm) | 0.56 × 0.17 × 0.15 |
Data collection | |
Diffractometer | Bruker SMART APEXII CCD area-detector diffractometer |
Absorption correction | Multi-scan (SADABS; Bruker, 2005) |
Tmin, Tmax | 0.950, 0.986 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 4616, 1296, 1208 |
Rint | 0.026 |
(sin θ/λ)max (Å−1) | 0.682 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.041, 0.116, 1.07 |
No. of reflections | 1296 |
No. of parameters | 101 |
H-atom treatment | All H-atom parameters refined |
Δρmax, Δρmin (e Å−3) | 0.42, −0.24 |
Computer programs: APEX2 (Bruker, 2005), SAINT (Bruker, 2005), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2003).
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1N1···N2i | 0.87 (2) | 2.18 (2) | 3.0060 (13) | 158.1 (15) |
C2—H2B···Cg1ii | 1.015 (15) | 2.980 (15) | 3.8882 (11) | 149.6 (11) |
Symmetry codes: (i) x, y−1, z; (ii) −x, −y+1, −z+1. |
Acknowledgements
HKF and RK thank the Malaysian Government and Universiti Sains Malaysia for a Science Fund grant (No. 305/PFIZIK/613312). RK thanks Universiti Sains Malaysia for a postdoctoral research fellowship. HK thanks PNU for financial support. HKF also thanks Universiti Sains Malaysia for a Research University Golden Goose grant (No. 1001/PFIZIK/811012).
References
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573. CrossRef CAS Web of Science Google Scholar
Blancafort, P. (1978). Drugs Fut. 3, 592–592. CrossRef Google Scholar
Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Chan, S. (1993). Clin. Sci. 85, 671–677. CAS PubMed Web of Science Google Scholar
Corey, E. J. & Grogan, M. J. (1999). Org. Lett. 1, 157–160. Web of Science CSD CrossRef PubMed CAS Google Scholar
Li, H. Y., Drummond, S., De Lucca, I. & Boswell, G. A. (1996). Tetrahedron, 52, 11153–11162. CSD CrossRef CAS Web of Science Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Spek, A. L. (2003). J. Appl. Cryst. 36, 7–13. Web of Science CrossRef CAS IUCr Journals Google Scholar
Stibrany, R. T., Schugar, H. J. & Potenza, J. A. (2004). Acta Cryst. E60, o527–o529. Web of Science CSD CrossRef IUCr Journals Google Scholar
Ueno, M., Imaizumi, K., Sugita, T., Takata, I. & Takeshita, M. (1995). Int. J. Immunopharmacol. 17, 597–603. CrossRef CAS PubMed Web of Science Google Scholar
Vizi, E. S. (1986). Med. Res. Rev. 6, 431–449. CrossRef CAS PubMed Web of Science Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
Imidazoline derivatives are of great importance because they exhibit significant biological and pharmacological activities including anti-hypertensive (Blancafort 1978), anti-hyperglycemic (Chan 1993), anti-depressive (Vizi 1986), anti-hypercholesterolemic (Li et al., 1996) and anti-inflammatory (Ueno et al., 1995) activities. These compounds are also used as catalysts and synthetic intermediates in some organic reactions (Corey & Grogan 1999). In consideration of the important applications of imidazolines, herein the crystal structure of the title compound, (I), is reported.
In compound (I), Fig. 1, bond lengths and angles are within the normal ranges and are comparable with a related structure (Stibrany et al., 2004). The molecule lies about a crystallographic inversion centre. The five- and six-membered rings are twisted from each other, forming a dihedral angle of 18.06 (7)°. Intermolecular N—H···N hydrogen bonds form 18-membered rings producing R22(18) ring motifs to link molecules into one-dimensional infinite chains along the b-axis, Table 1 and Fig. 2. The crystal structure is further stabilized by weak intermolecular π–π stacking [Cg1···Cg2i = 3.8254 (6) Å; (i) 1 + x, y, z] and C—H···π (Cg1 and Cg2 are the centroids of the N1/C1/C2/N2/C3 imidazoline ring and the benzene ring, respectively) interactions, Table 1.